Agabiti-Rosei E - Search Results

1

Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.

Januszewicz A, Mulatero P, Dobrowolski P, Monticone S, Van der Niepen P, Sarafidis P, Reincke M, Rexhaj E, Eisenhofer G, Januszewicz M, Kasiakogias A, Kreutz R, Lenders JWM, Muiesan ML, Persu A, Agabiti-Rosei E, Soria R, Śpiewak M, Prejbisz A, Messerli FH. Januszewicz A, et al. Among authors: agabiti rosei e. J Am Coll Cardiol. 2022 Oct 11;80(15):1480-1497. doi: 10.1016/j.jacc.2022.08.714. J Am Coll Cardiol. 2022. PMID: 36202538 Free article. Review.

2

Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.

Agabiti-Rosei E, Muiesan ML, Rizzoni D, Zulli R, Calebich S, Beschi M, Castellano M, Muiesan G. Agabiti-Rosei E, et al. J Hum Hypertens. 1992 Feb;6(1):9-15. J Hum Hypertens. 1992. PMID: 1349920

3

Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring.

Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Rizzoni D, et al. Am J Hypertens. 1992 Mar;5(3):180-6. doi: 10.1093/ajh/5.3.180. Am J Hypertens. 1992. PMID: 1575945

4

Perindopril versus captopril: efficacy and acceptability in an Italian multicenter trial.

Agabiti-Rosei E, Ambrosioni E, Finardi G, Folino P, Gambassi G, Malini P, Marchesi E, Muiesan ML, Semplicini A, Pessina AC. Agabiti-Rosei E, et al. Am J Med. 1992 Apr 27;92(4B):79S-83S. doi: 10.1016/0002-9343(92)90153-3. Am J Med. 1992. PMID: 1580285 Clinical Trial.

5

Exercise-induced modifications in cardiorespiratory parameters of hypertensive patients treated with calcium antagonists.

Fariello R, Boni E, Corda L, Muiesan ML, Agabiti-Rosei E. Fariello R, et al. J Hypertens Suppl. 1991 Dec;9(3):S67-72. J Hypertens Suppl. 1991. PMID: 1686784 Review.

6

Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.

Agabiti-Rosei E, Muiesan ML, Rizzoni D, Romanelli G, Beschi M, Castellano M. Agabiti-Rosei E, et al. J Cardiovasc Pharmacol. 1991;18 Suppl 5:S5-9. J Cardiovasc Pharmacol. 1991. PMID: 1725798

7

Left ventricular systolic function during stress as related to impaired diastolic filling in essential hypertension.

Muiesan ML, Rizzoni D, Zulli R, Calebich S, Agabiti-Rosei E. Muiesan ML, et al. J Hypertens Suppl. 1991 Dec;9(6):S152-3. J Hypertens Suppl. 1991. PMID: 1818921 No abstract available.

8

Plasma norepinephrine and spectral analysis of the heart rate during cardiopulmonary receptor stimulation in normal and hypertensive subjects.

Rizzoni D, Castellano M, Beschi M, Muiesan ML, Bettoni G, Porteri E, Agabiti-Rosei E. Rizzoni D, et al. J Hypertens Suppl. 1991 Dec;9(6):S84-5. J Hypertens Suppl. 1991. PMID: 1819021 No abstract available.

9

Reversal of cardiovascular structural changes during long-term antihypertensive therapy.

Agabiti-Rosei E, Muiesan ML. Agabiti-Rosei E, et al. J Hum Hypertens. 1991 Aug;5 Suppl 1:41-7. J Hum Hypertens. 1991. PMID: 1834845 Review.

10

Ventricular arrhythmias and changes in blood pressure and left ventricular mass induced by antihypertensive treatment in hypertensive patients.

Malerba M, Muiesan ML, Zulli R, Rizzoni D, Calebich S, Agabiti-Rosei E. Malerba M, et al. J Hypertens Suppl. 1991 Dec;9(6):S162-3. J Hypertens Suppl. 1991. PMID: 1840186 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters